Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avet-Loiseau

Showing results (1-10 of 381) with videos related to

Pageof 39
Sort By:
British Journal of Haematology|May 3, 2000
Reply to drach et alAvet-Loiseau
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Minimal Residual Disease by Next-Generation Sequencing: Pros and ConsHerve Avet-Loiseau
Best Practice & Research. Clinical Haematology|December 12, 2007
Role of genetics in prognostication in myelomaHervé Avet-Loiseau
Hematology. American Society of Hematology. Education Program|January 18, 2011
Ultra high-risk myelomaHervé Avet-Loiseau
Leukemia & Lymphoma|May 26, 1999
Fish analysis at diagnosis in acute lymphoblastic leukemiaH Avet-Loiseau
Blood|December 28, 2018
Introduction to a review series on advances in multiple myelomaHervé Avet-Loiseau
Blood|May 13, 2022
Introduction to a How I Treat series on plasma cell dyscrasiasHervé Avet-Loiseau
Cancer Journal (Sudbury, Mass.)|January 30, 2019
Risk-Based Therapeutic StrategiesJill Corre, Hervé Avet-Loiseau
Blood|October 9, 1998
Detection of nonrandom chromosomal changes in multiple myeloma by comparative genomic hybridizationH Avet-Loiseau, R Bataille
Journal of the National Comprehensive Cancer Network : JNCCN|October 7, 2011
The impact of genomics on the management of myelomaJill Corre, Hervé Avet-Loiseau
Pageof 39

Showing results (1-10 of 381) with videos related to

Sort By:
Pageof 39
British Journal of Haematology|May 3, 2000
Reply to drach et alAvet-Loiseau
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Minimal Residual Disease by Next-Generation Sequencing: Pros and ConsHerve Avet-Loiseau
Best Practice & Research. Clinical Haematology|December 12, 2007
Role of genetics in prognostication in myelomaHervé Avet-Loiseau
Hematology. American Society of Hematology. Education Program|January 18, 2011
Ultra high-risk myelomaHervé Avet-Loiseau
Leukemia & Lymphoma|May 26, 1999
Fish analysis at diagnosis in acute lymphoblastic leukemiaH Avet-Loiseau
Blood|December 28, 2018
Introduction to a review series on advances in multiple myelomaHervé Avet-Loiseau
Blood|May 13, 2022
Introduction to a How I Treat series on plasma cell dyscrasiasHervé Avet-Loiseau
Cancer Journal (Sudbury, Mass.)|January 30, 2019
Risk-Based Therapeutic StrategiesJill Corre, Hervé Avet-Loiseau
Blood|October 9, 1998
Detection of nonrandom chromosomal changes in multiple myeloma by comparative genomic hybridizationH Avet-Loiseau, R Bataille
Journal of the National Comprehensive Cancer Network : JNCCN|October 7, 2011
The impact of genomics on the management of myelomaJill Corre, Hervé Avet-Loiseau
Pageof 39